PMID:18230659
| Citation |
Walsh, JS, Eastell, R and Peel, NF (2008) Effects of Depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J. Clin. Endocrinol. Metab. 93:1317-23 |
|---|---|
| Abstract |
Depot medroxyprogesterone acetate (DMPA; Depo-Provera, Tadworth, UK) contraception is used by more than 9 million women worldwide and has a high usage among teenagers in the United Kingdom and the United States. Previous studies have found that DMPA use is associated with a bone density deficit. |
| Links |
PubMed Online version:10.1210/jc.2007-2201 |
| Keywords |
Adolescent; Adult; Bone Density/drug effects; Bone Remodeling/drug effects; Case-Control Studies; Estradiol/blood; Female; Humans; Medroxyprogesterone Acetate/adverse effects; Middle Aged; Parathyroid Hormone/blood; Regression Analysis |
| edit table |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
<annotationlinks/>
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
References
See Help:References for how to manage references in EcoliWiki.